StonvexLoading…
StonvexStonvexStonvexCore line items from ABNB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.24B | $11.10B | $9.92B | $8.40B |
Operating Income | $2.54B | $2.55B | $1.52B | $1.80B |
Net Income | $2.51B | $2.65B | $4.79B | $1.89B |
EPS (Diluted) | $4.03 | $4.11 | $7.24 | $2.79 |
Total Assets | $22.21B | $20.96B | $20.64B | $16.04B |
Total Liabilities | $14.01B | $12.55B | $12.48B | $10.48B |
Cash & Equivalents | $6.56B | $6.86B | $6.87B | $7.38B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $3.40B |
Shares Outstanding | 623.00M | 645.00M | 662.00M | 680.00M |